📣 VC round data is live. Check it out!

M3 Inc. Valuation Multiples

Discover revenue and EBITDA valuation multiples for M3 Inc. and similar public comparables like Glaukos, Kakaku.com, Doximity, Waystar and more.

M3 Inc. Overview

About M3 Inc.

M3 Inc is a Japan-based company engaged in providing medical-related services through internet-based platforms and real-world operations. The company operates six reportable segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, Patient Solutions, and Overseas. Its businesses include online marketing for medical professionals, clinical trial support, human resources services for medical professionals, operational support for medical institutions, and patient support services. The Overseas segment offers similar services internationally, including in the United States, the United Kingdom, China, South Korea, India, France, Germany, and Spain.


Founded

2000

HQ

Japan

Employees

18.4K

Financials (LTM)

Revenue: $2B
EBITDA: $591M

EV

$5B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

M3 Inc. Financials

M3 Inc. reported last 12-month revenue of $2B and EBITDA of $591M.

In the same LTM period, M3 Inc. generated $1B in gross profit, $591M in EBITDA, and $318M in net income.

Revenue (LTM)


M3 Inc. P&L

In the most recent fiscal year, M3 Inc. reported revenue of $2B and EBITDA of $488M.

M3 Inc. is profitable as of last fiscal year, with gross margin of 54%, EBITDA margin of 27%, and net margin of 14%.

See analyst estimates for M3 Inc.
LTMLast FY202320242025202620272028
Revenue$2B$2B$1B$2B$2B
Gross Profit$1B$969M$874M$947M$1B
Gross Margin50%54%59%55%51%
EBITDA$591M$488M$496M$488M$560M
EBITDA Margin26%27%33%28%26%
EBIT Margin21%21%27%22%21%
Net Profit$318M$254M$290M$262M$298M
Net Margin14%14%20%15%14%

Financial data powered by Morningstar, Inc.

M3 Inc. Stock Performance

M3 Inc. has current market cap of $6B, and enterprise value of $5B.

Market Cap Evolution


M3 Inc.'s stock price is $8.94.

M3 Inc. share price decreased by 28.5% in the last year.

M3 Inc. has an EPS (earnings per share) of $0.38.

See more trading valuation data for M3 Inc.
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$5B$6B0.0%--11.6%-28.5%$0.38

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

M3 Inc. Valuation Multiples

M3 Inc. trades at 2.2x EV/Revenue multiple, and 8.5x EV/EBITDA.

See NTM and 2027E valuation multiples for M3 Inc.

EV / Revenue (LTM)


M3 Inc. Financial Valuation Multiples

As of June 1, 2026, M3 Inc. has market cap of $6B and EV of $5B.

M3 Inc. has a P/E ratio of 18.8x.

LTMLast FY202320242025202620272028
EV/Revenue2.2x2.8x3.4x2.9x2.4x
EV/EBITDA8.5x10.3x10.1x10.2x8.9x
EV/EBIT10.5x13.2x12.3x13.1x11.2x
EV/Gross Profit4.4x5.2x5.7x5.3x4.6x
P/E18.8x23.5x20.6x22.8x20.0x
EV/FCF14.8x18.6x15.8x17.8x15.0x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified M3 Inc. Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

M3 Inc. Margins & Growth Rates

M3 Inc. grew revenue by 25% and EBITDA by 20% in the last fiscal year.

In the most recent fiscal year, M3 Inc. reported gross margin of 54%, EBITDA margin of 27%, and net margin of 14%.

See estimated margins and future growth rates for M3 Inc.

M3 Inc. Margins

Last FY202420252026202720282029
Gross Margin54%55%51%50%
EBITDA Margin27%28%26%26%
EBIT Margin21%22%21%21%
Net Margin14%15%14%14%
FCF Margin15%16%16%12%

M3 Inc. Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth25%15%24%13%
Gross Profit Growth16%8%14%11%
EBITDA Growth20%(2%)15%10%
EBIT Growth24%(6%)16%14%
Net Profit Growth23%(10%)14%13%
FCF Growth32%(11%)19%(15%)

Data powered by FactSet, Inc. and Morningstar, Inc.

M3 Inc. Operational KPIs

M3 Inc.'s revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

M3 Inc.'s Rule of 40 is 39% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

M3 Inc.'s Rule of X is 59% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for M3 Inc.
LTMLast FY202320242025202620272028
Rule of 4036%39%---
Bessemer Rule of X51%59%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.0M---
G&A Expenses to Revenue-33%31%32%27%
Opex to Revenue-33%31%33%28%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

M3 Inc. Competitors

M3 Inc. competitors include Glaukos, Kakaku.com, Doximity, Waystar, IAC, Kadokawa, People.cn, Tieto, CCC Intelligent Solutions and Pro Medicus.

Most M3 Inc. public comparables operate across Healthcare Software, Online Content & News, B2B SaaS, HealthTech and Vertical SaaS.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Glaukos11.6x10.6x(179.0x)1970.8x
Kakaku.com7.8x6.2x18.4x19.2x
Doximity4.9x4.9x8.9x9.0x
Waystar4.7x4.4x11.1x10.4x
IAC1.5x1.7x13.4x14.3x
Kadokawa1.3x1.3x14.2x19.7x
People.cn8.4x-43.6x-
Tieto1.5x1.5x7.3x9.3x

This data is available for Pro users. Sign up to see all M3 Inc. competitors and their valuation data.

Start Free Trial

M3 Inc. M&A Activity

M3 Inc. has acquired 11 companies to date.

Last acquisition by M3 Inc. was on June 3rd 2024. M3 Inc. acquired MinaCare for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by M3 Inc.

MinaCare
On-call Collaboration Platform
Messly
Logic
Description
MinaCare is a healthcare provider offering preventive health management, data analytics, and operational support services in Japan. Tokyo-based, MinaCare delivers corporate wellness programs, electronic health records integration, and AI-driven risk assessments to clinics and enterprises. Its platform processes patient data for personalized care plans and compliance reporting under Japanese regulations. MinaCare serves mid-sized hospitals and insurance firms with telemedicine tools.
On-call Collaboration Platform, known as Tochoku, is a Tokyo-based service connecting medical facilities with temporary healthcare staff in Japan. The platform facilitates shift bookings for nurses, caregivers, and administrative roles, alongside document preparation for compliance and HR management tools. Hospitals and clinics use it to address staffing shortages during peak periods or emergencies.
Messly is a London-based professional network for doctors facilitating job discovery, temporary placements, and career development in the UK's NHS. The SaaS platform connects physicians with hospitals and provides peer insights on training opportunities.
Logic is a Tokyo-based software developer of the Care Wing system for elderly care providers. Established in 1995, the platform digitizes caregiver records via smartphones, automating reports and seminar scheduling. It distributes care information across Japanese facilities.
HQ CountryJapanJapanUnited KingdomJapan
HQ City
Tokyo
Tokyo
London
Kanazawa
Deal Date3 Jun 20241 Apr 202421 Aug 20231 Mar 2022
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all M3 Inc. acquisitions and their M&A valuation multiples.

Start Free Trial

M3 Inc. Investment Activity

M3 Inc. has invested in 22 companies to date.

Latest investment by M3 Inc. was on January 29th 2025. M3 Inc. invested in Zest in their $600K Series B round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by M3 Inc.

Zest
Valt Japan
Chefaa
Segmed
Description
-
Valt Japan is a Tokyo-based social enterprise addressing community issues through business initiatives. The company develops programs in elderly care, education, and environmental sustainability, partnering with local governments and NGOs in Japan. Valt Japan operates projects like community centers and recycling systems.
Chefaa is a Cairo-based digital pharmacy platform using GPS to connect Egyptian patients with over 3,000 nationwide pharmacies for prescription fulfillment and chronic disease management. Available via app and chefaa.com, it handles medicine delivery, reminders, and consultations for conditions like diabetes and hypertension. The service integrates insurance processing to streamline access in urban and rural areas.
Segmed is a medical data platform based in Warsaw, Poland. It supplies de-identified clinical data and diagnostic-grade images from 1,500 hospitals across 50 countries to life sciences and medtech firms. The repository includes X-rays, CT scans, and MRIs linked to outcomes for AI model training. Segmed supports pharmaceutical trials and device validation, partnering with GE Healthcare and accelerating FDA submissions through compliant datasets.
HQ CountryJapanJapanEgyptUnited States
HQ City
-
Tokyo
Cairo
San Francisco, CA
Deal Date29 Jan 20259 Jan 202417 Dec 202314 Nov 2022
RoundSeries BSeries BSeedSeed
Raised$600K$3M$5M$5M
InvestorsM3 Inc.; SMS; WisemanBricks Fund Tokyo; M3 Inc.; MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC); NOBUNAGA Capital VillageGlobal Brain Corporation; GMS Capital Partners; M3 Inc.; Newtown Partners; Verod-Kepple Africa VenturesAlchemist Accelerator; Expeditions Fund; iGan Partners; M3 Inc.; Mighty Capital; Nina Capital
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all M3 Inc. investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About M3 Inc.

When was M3 Inc. founded?M3 Inc. was founded in 2000.
Where is M3 Inc. headquartered?M3 Inc. is headquartered in Japan.
How many employees does M3 Inc. have?As of today, M3 Inc. has over 18K employees.
Is M3 Inc. publicly listed?Yes, M3 Inc. is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of M3 Inc.?M3 Inc. trades under 2413 ticker.
When did M3 Inc. go public?M3 Inc. went public in 2004.
Who are competitors of M3 Inc.?M3 Inc. main competitors include Glaukos, Kakaku.com, Doximity, Waystar, IAC, Kadokawa, People.cn, Tieto, CCC Intelligent Solutions, Pro Medicus.
What is the current market cap of M3 Inc.?M3 Inc.'s current market cap is $6B.
What is the current revenue of M3 Inc.?M3 Inc.'s last 12 months revenue is $2B.
What is the current revenue growth of M3 Inc.?M3 Inc. revenue growth (NTM/LTM) is 10%.
What is the current EV/Revenue multiple of M3 Inc.?Current revenue multiple of M3 Inc. is 2.2x.
What is the current EBITDA of M3 Inc.?M3 Inc.'s last 12 months EBITDA is $591M.
What is M3 Inc.'s EBITDA margin?M3 Inc.'s last 12 months EBITDA margin is 26%.
What is the current EV/EBITDA multiple of M3 Inc.?Current EBITDA multiple of M3 Inc. is 8.5x.
What is the current FCF of M3 Inc.?M3 Inc.'s last 12 months FCF is $339M.
What is M3 Inc.'s FCF margin?M3 Inc.'s last 12 months FCF margin is 15%.
What is the current EV/FCF multiple of M3 Inc.?Current FCF multiple of M3 Inc. is 14.8x.
How many companies M3 Inc. has acquired to date?As of June 2026, M3 Inc. has acquired 11 companies.
What was the largest acquisition by M3 Inc.?$13M acquisition of Y's on 30th August 2018 was the largest M&A M3 Inc. has done to date.
In how many companies M3 Inc. has invested to date?As of June 2026, M3 Inc. has invested in 22 companies.
What was the last M3 Inc. investment?On 29th January 2025 M3 Inc. invested in Zest, participating in a $600K Series B round, alongside SMS and Wiseman.
In what companies M3 Inc. invested in?M3 Inc. invested in RelianceHMO, Reliance Health, Carepoint Hospitals, Africa Health Holdings Ltd, Raksul, Cyfuse Biomedical, Empheal, StemRIM, Perseus Proteomics, CellAxia, Susmed, Chefaa, Segmed, Japanese Organization for Medical Device Development, Valt Japan, Epigno, Connect Japan, Cardio Intelligence, Aptpod, MediGear International, and 2 other companies.

See public comps similar to M3 Inc.

Lists including M3 Inc.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial